ResearcherFred Hutch Cancer CenterNo recent work listed
Marsha L. Frazier
Matched on OpenAlex author ID A5112024668; NIH RePORTER profile ID 1967897. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 5)
- Trials
- 0
- Grants
- 1
- Labs led
- 1
- Collaborators
- 31
2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 3 papers · 2015: 2 papers, 1 grant · 2016: 1 paper · 2017: 1 paper
Papers 10
- A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djw341↗
- Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Last author DOI 10.18632/oncotarget.10924↗
- Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. Last author DOI 10.1097/mpa.0000000000000263↗
- Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
- Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Last author DOI 10.1002/mc.22023↗
- Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer. First author DOI 10.1007/s10620-013-2938-9↗
- Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Co-author DOI 10.7150/jca.10094↗
- A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Last author DOI 10.1002/mc.20808↗
- Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Last author DOI 10.1097/mpa.0b013e318219dafe↗
- A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Co-author DOI 10.1158/1940-6207.capr-10-0025↗
Grants 1
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Subrata Sen · 8 shared papers, 1 shared grant, 2011–2017 · strength 0.50
- Grant Biomarkers for the Early Detection of Pancreatic Cancer U01CA111302↗
- Paper Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of… DOI 10.18632/oncotarget.10924↗
- Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
- Ann McNeill Killary · 8 shared papers, 1 shared grant, 2011–2017 · strength 0.50
- Grant Biomarkers for the Early Detection of Pancreatic Cancer U01CA111302↗
- Paper Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of… DOI 10.18632/oncotarget.10924↗
- Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
- Randall E. Brand · 4 shared papers, 2015–2017 · strength 0.21
- Paper Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of… DOI 10.18632/oncotarget.10924↗
- Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
- Paper Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact… DOI 10.1097/mpa.0000000000000263↗
- Jinyun Chen · 5 shared papers, 2011–2016 · strength 0.20
- Paper Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of… DOI 10.18632/oncotarget.10924↗
- Paper Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal… DOI 10.1002/mc.22023↗
- Paper Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. DOI 10.7150/jca.10094↗
- Chongjuan Wei · 3 shared papers, 2012–2014 · strength 0.13
- Paper Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer. DOI 10.1007/s10620-013-2938-9↗
- Paper Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal… DOI 10.1002/mc.22023↗
- Paper A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic du… DOI 10.1002/mc.20808↗
- Seetharaman Balasenthil · 3 shared papers, 2011–2017 · strength 0.12
- Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
- Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
- Paper A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. DOI 10.1158/1940-6207.capr-10-0025↗
- Sudhir Srivastava · 2 shared papers, 2015–2017 · strength 0.10
- Ying Huang · 2 shared papers, 2015–2017 · strength 0.10
- Xifeng Wu · 2 shared papers, 2011–2016 · strength 0.09
- Wei Chen · 1 shared paper, 2016 · strength 0.06
- Suyu Liu · 1 shared paper, 2017 · strength 0.06
- Jill Palmer Smith · 1 shared paper, 2015 · strength 0.06
- Gail L. Matters · 1 shared paper, 2015 · strength 0.06
- David Clement Whitcomb · 1 shared paper, 2015 · strength 0.06
- Yu-Jing Huang · 1 shared paper, 2014 · strength 0.06
- Qian Liu · 1 shared paper, 2014 · strength 0.04
- Jin Wang · 1 shared paper, 2014 · strength 0.04
- Jin Wang · 1 shared paper, 2014 · strength 0.04
- Xiaoqun Dong · 1 shared paper, 2014 · strength 0.04
- Sushovan Guha · 1 shared paper, 2014 · strength 0.04
- Michael B. Wallace · 1 shared paper, 2014 · strength 0.04
- Massimo Raimondo · 1 shared paper, 2014 · strength 0.04
- Herbert J. Zeh · 1 shared paper, 2015 · strength 0.04
- Peter J. Allen · 1 shared paper, 2015 · strength 0.04
- Michael Anthony Hollingsworth · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.